Test information on BRH covid 19 approach6 Aug 2020 04:08
After seeinf yesterday's RNS on a 5 minute test result, did some Googling on BRH:
* Aptamer based test.
* Sheffield University involvement is the electronic sensor.
* Another UK University is supplying the Aptamer.
Which Covid-19 test is going to sweep the board comes down to the Sensitivity vs Specificity vs cost vs time for test result and how problematic the supply chain is for whatever the test needs.
Or that is how it should be, but I am not sure what confidence I have in the UK government's procurement processes.The DnaNudge approach seems very complicated, but maybe it was available amongst a limited number of competitors at an early time and so got evaluated.
Invested in NCYT and AVCT.
The clever part of the Avacta/Cytiva approach is not needing a machine to process the test, but does this feature come at a increased overall cost per test compared to BRH when the machine used for BRH test is used for thousands or tens of thousands of tests. Does anyone know the BRH test approach?
I don't have enough information to decide, but a market cap of £6M warrants further investigation.
Zak Mir was targetting a return to the recent high.